🧬 Hybridoma Monoclonal Antibody Production


Overview
- Used to produce monoclonal antibodies (mAbs)
Steps
Step | Description |
1. Immunization | Mouse is immunized with antigen to generate antibody response. |
2. Booster Dose | Given after measuring antibody titers. |
3. Spleen Cell Isolation | Mouse is euthanized Spleen cells (B-lymphocytes) are harvested. |
4. Fusion with Myeloma Cells | Spleen cells + myeloma cells (unlimited growth) â–º using PEG |
5. Hybridoma Formation | Cells with antibody production + immortal growth. |
6. Selection in HAT Medium (Hypoxanthine, Aminopterin and Thymidine) | Only hybridomas survive (via salvage pathway; myeloma cells die due to lack of HGPRT). |
7. Screening & Cloning | Screen for desired antibody-producing hybridomas and clone them. |
8. Antibody Harvesting | Cultured to harvest monoclonal antibodies. |
HAT Medium Components & Function
Component | Function |
Hypoxanthine | Substrate for salvage pathway. |
Aminopterin | Folate antagonists â›” de novo nucleotide or purine synthesis. |
Thymidine | Allows DNA synthesis via salvage pathway. |
Enzymes
- HGPRT (Hypoxanthine-Guanine Phosphoribosyltransferase)
- Thymidine Kinase
Applications
Field | Application |
Therapeutics | Immunosuppressants, mAb therapy (e.g., for cancer, autoimmune diseases) |
Research | Listing lymphocyte subpopulations, antigen quantification |
Diagnostics | ELISA, blood component assays |
Â